// App-Quantinova.ai

P153 : Rituximab and tocilizumab and their effect on lung disease progression in scleroderma: a retrospective cohort study at a single centre

Researchers

Presenter

  • Nina R Goldman

Principal Investigators

  • Aoife Tynan

  • Claire Beesley

  • Rizgar Mageed

  • Christopher Denton

  • Voon H Ong

Medical Centers

  • Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

  • University College London Hospital, Department of Pathology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

  • Rituximab

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved